Loading...

Pacific Blue™ anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_Blue_091207
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) Pacific Blue™ (filled histogram) or rat IgG2a, κ Pacific Blue™ isotype control (open histogram).
  • 53-6dot7_Blue_091207
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) Pacific Blue™ (filled histogram) or rat IgG2a, κ Pacific Blue™ isotype control (open histogram).
See Pacific Blue™ spectral data
Cat # Size Price Quantity Check Availability Save
100728 25 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100725 100 µg 172€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue™ under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  2. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  3. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  4. Sokol CL et al. 2018. Immunity. 49(3):449-463 . PubMed
  5. Jasti S, et al. 2017. Biol Reprod. 96:134. PubMed
  6. Melissa M Remy et al. 2017. Cell host & microbe. 22(3):354-365 . PubMed
  7. Van Braeckel-Budimir N, et al. 2018. Cell Rep. 24:3374. PubMed
  8. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  9. Engblom C, et al. 2017. Science. 358:6367. PubMed
  10. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  11. Page N, et al. 2018. Immunity. 48:937. PubMed
  12. Schneider C, et al. 2018. Cell. 174:271. PubMed
  13. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  14. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  15. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  16. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  17. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  18. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  19. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  20. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  21. Terashima Y, et al. 2020. Nat Commun. 11:609. PubMed
  22. Mohebiany AN, et al. 2020. Cell Reports. 30(5):1585-1597.e6.. PubMed
  23. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  24. Molofsky A, et al. 2013. J Exp Med. 210:535. PubMed
  25. Price J, et al. 2015. Diabetes. 64: 3521 - 3531. PubMed
  26. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  27. Ren Y, et al. 2015. Sci Rep. 5: 18099. PubMed
  28. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  29. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  30. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  31. Atkinson S, et al. 2016. Dis Model Mech. 9: 427-440. PubMed
  32. Tian Y, et al. 2016. J Immunol. 197: 1308 - 1321. PubMed
  33. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  34. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  35. Engler J, et al. 2017. Proc Natl Acad Sci U S A. 114(2):E181-E190. PubMed
  36. Galeano Niño JL, et al. 2020. J Cell Sci. 133:00:00. PubMed
  37. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  38. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  39. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  40. Chen Y, et al. 2020. Virol Sin. . PubMed
  41. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  42. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  43. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  44. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  45. Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
  46. Saito S, et al. 2020. Nutrients. 12:. PubMed
  47. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  48. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  49. Ontiveros-Padilla L, et al. 2021. Microorganisms. 9:. PubMed
  50. Chen D, et al. 2021. JCI Insight. 6:. PubMed
  51. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  52. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  53. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  54. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  55. Zhu W, et al. 2021. Onco Targets Ther. 14:2149. PubMed
  56. Galeano Niño JL, et al. 2020. J Cell Sci. . PubMed
  57. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
  58. Chun N, et al. 2021. JCI Insight. 6:. PubMed
  59. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  60. Wang X, et al. 2022. Elife. 11:. PubMed
  61. Blanchard L, et al. 2022. STAR Protoc. 3:101444. PubMed
  62. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  63. Gu M, et al. 2021. Nat Immunol. 22:193. PubMed
  64. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  65. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  66. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  67. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  68. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  69. O'Leary CE, et al. 2021. Curr Protoc. 1:e77. PubMed
  70. Lou Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  71. Gawish R, et al. 2022. Elife. 11:. PubMed
  72. Tian Q, et al. 2022. Front Mol Neurosci. 15:850904. PubMed
  73. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  74. Gawish R, et al. 2022. Elife. 11:. PubMed
  75. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  76. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  77. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  78. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  79. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  80. Balood M, et al. 2022. Nature. 611:405. PubMed
  81. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  82. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  83. Novaj A, et al. 2023. Int J Mol Sci. 24: . PubMed
  84. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  85. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  86. Fueyo-González F, et al. 2022. Immunity. 55:459. PubMed
  87. Olson SW, et al. 2022. Mol Cell. 82:1708. PubMed
  88. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  89. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  90. Ke F, et al. 2023. Elife. 12:. PubMed
  91. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
RRID
AB_493426 (BioLegend Cat. No. 100728)
AB_493425 (BioLegend Cat. No. 100725)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org
Go To Top Version: 2    Revision Date: 01/21/2014

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account